You have 9 free searches left this month | for more free features.

City

Baltimore (2)

Cambridge (1)

Portland (1)

Condition

Pulmonary Disease, Chronic Obstructive (3)

Delayed Cerebral Ischemia (1)

Endothelial Dysfunction (1)

Subarachnoid Hemorrhage, Aneurysmal (1)

Vasospasm, Cerebral (1)

Overall Status

Completed (4)

Sign in for free

Phase

phase 1 (3)

phase 1/phase 2 (1)

Sponsor

GlaxoSmithKline (3)

Oregon Health and Science University (1)

Collaborator

Foundation for Anesthesia Education and Research (1)

GlaxoSmithKline (1)

Parexel (1)

Intervention

gsk2256294 (4)

placebo (3)

Study Documents

Annotated Case Report Form (3)

Clinical Study Report (3)

Dataset Specification (3)

Individual Participant Data Set (3)

Informed Consent Form (3)

Statistical Analysis Plan (3)

Study Protocol (3)

Intervention Type

drug (4)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

gsk2256294

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia, Vasospasm, Cerebral Trial in Portland (GSK2256294, Placebo)

Completed

Subarachnoid Hemorrhage, Aneurysmal
+3 more

GSK2256294
Placebo

Portland, Oregon

Oregon Health & Science University

Dec 31, 2020

Pulmonary Disease, Chronic Obstructive Trial in Baltimore (GSK2256294)

Completed

Pulmonary Disease, Chronic Obstructive

GSK2256294

Baltimore, Maryland

GSK Investigational Site

May 5, 2017

Pulmonary Disease, Chronic Obstructive Trial in Cambridge (GSK2256294, Placebo)

Completed

Pulmonary Disease, Chronic Obstructive

GSK2256294
Placebo

Cambridge, United Kingdom

GSK Investigational Site

May 5, 2017

Pulmonary Disease, Chronic Obstructive Trial in Baltimore (GSK2256294, Placebo)

Completed

Pulmonary Disease, Chronic Obstructive

GSK2256294
Placebo

Baltimore, Maryland

GSK Investigational Site

May 5, 2017